10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
19.81
+0.67 (3.50%)
At close: Mar 24, 2026, 4:00 PM EDT
20.00
+0.19 (0.96%)
After-hours: Mar 24, 2026, 7:46 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.53 billion as of March 24, 2026. Its market cap has increased by 76.86% in one year.
Market Cap
2.53B
Enterprise Value
2.09B
1-Year Change
76.86%
Ranking
Category
Stock Price
$19.81
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.53B, a decrease of -48.88%. That is a compound annual growth rate of -9.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 2.45B | 18.46% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthEquity | 6.90B |
| Waystar Holding | 4.72B |
| Doximity | 4.62B |
| Hinge Health | 3.32B |
| Privia Health Group | 2.65B |
| HeartFlow | 2.30B |
| Omnicell | 1.56B |
| Certara | 1.01B |